FRESENIUS MEDICAL CARE AG (FME.DE) Fundamental Analysis & Valuation

FRA:FME • DE0005785802

Current stock price

39.3 EUR
+0.63 (+1.63%)
Last:

This FME.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. FME.DE Profitability Analysis

1.1 Basic Checks

  • FME had positive earnings in the past year.
  • In the past year FME had a positive cash flow from operations.
  • FME had positive earnings in each of the past 5 years.
  • FME had a positive operating cash flow in each of the past 5 years.
FME.DE Yearly Net Income VS EBIT VS OCF VS FCFFME.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.16%, FME is in the better half of the industry, outperforming 65.52% of the companies in the same industry.
  • FME has a Return On Equity (7.35%) which is in line with its industry peers.
  • The Return On Invested Capital of FME (5.30%) is comparable to the rest of the industry.
  • The Average Return On Invested Capital over the past 3 years for FME is below the industry average of 6.20%.
  • The 3 year average ROIC (4.02%) for FME is below the current ROIC(5.30%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.16%
ROE 7.35%
ROIC 5.3%
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
FME.DE Yearly ROA, ROE, ROICFME.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • FME's Profit Margin of 4.98% is amongst the best of the industry. FME outperforms 82.76% of its industry peers.
  • In the last couple of years the Profit Margin of FME has declined.
  • FME's Operating Margin of 9.00% is fine compared to the rest of the industry. FME outperforms 75.86% of its industry peers.
  • FME's Operating Margin has declined in the last couple of years.
  • The Gross Margin of FME (25.62%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of FME has declined.
Industry RankSector Rank
OM 9%
PM (TTM) 4.98%
GM 25.62%
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
FME.DE Yearly Profit, Operating, Gross MarginsFME.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

5

2. FME.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so FME is still creating some value.
  • The number of shares outstanding for FME has been reduced compared to 1 year ago.
  • FME has less shares outstanding than it did 5 years ago.
  • FME has a worse debt/assets ratio than last year.
FME.DE Yearly Shares OutstandingFME.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
FME.DE Yearly Total Debt VS Total AssetsFME.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • FME has an Altman-Z score of 1.82. This is not the best score and indicates that FME is in the grey zone with still only limited risk for bankruptcy at the moment.
  • FME's Altman-Z score of 1.82 is in line compared to the rest of the industry. FME outperforms 55.17% of its industry peers.
  • FME has a debt to FCF ratio of 6.19. This is a slightly negative value and a sign of low solvency as FME would need 6.19 years to pay back of all of its debts.
  • FME has a better Debt to FCF ratio (6.19) than 75.86% of its industry peers.
  • A Debt/Equity ratio of 0.65 indicates that FME is somewhat dependend on debt financing.
  • With an excellent Debt to Equity ratio value of 0.65, FME belongs to the best of the industry, outperforming 82.76% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 6.19
Altman-Z 1.82
ROIC/WACC1.06
WACC5.01%
FME.DE Yearly LT Debt VS Equity VS FCFFME.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

2.3 Liquidity

  • FME has a Current Ratio of 1.26. This is a normal value and indicates that FME is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.26, FME is in the better half of the industry, outperforming 75.86% of the companies in the same industry.
  • FME has a Quick Ratio of 1.26. This is a bad value and indicates that FME is not financially healthy enough and could expect problems in meeting its short term obligations.
  • FME has a better Quick ratio (0.92) than 68.97% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.92
FME.DE Yearly Current Assets VS Current LiabilitesFME.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

5

3. FME.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 32.00% over the past year.
  • Measured over the past years, FME shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.51% on average per year.
  • The Revenue has been growing slightly by 1.51% in the past year.
  • FME shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.91% yearly.
EPS 1Y (TTM)32%
EPS 3Y11.44%
EPS 5Y-1.51%
EPS Q2Q%58.24%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-0.29%

3.2 Future

  • The Earnings Per Share is expected to grow by 9.03% on average over the next years. This is quite good.
  • Based on estimates for the next years, FME will show a small growth in Revenue. The Revenue will grow by 3.69% on average per year.
EPS Next Y-6.53%
EPS Next 2Y2.07%
EPS Next 3Y6.69%
EPS Next 5Y9.03%
Revenue Next Year-0.21%
Revenue Next 2Y1.76%
Revenue Next 3Y2.08%
Revenue Next 5Y3.69%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
FME.DE Yearly Revenue VS EstimatesFME.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B 25B
FME.DE Yearly EPS VS EstimatesFME.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

6

4. FME.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 9.16, which indicates a very decent valuation of FME.
  • Compared to the rest of the industry, the Price/Earnings ratio of FME indicates a rather cheap valuation: FME is cheaper than 86.21% of the companies listed in the same industry.
  • FME is valuated cheaply when we compare the Price/Earnings ratio to 26.21, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 9.80, which indicates a very decent valuation of FME.
  • FME's Price/Forward Earnings ratio is rather cheap when compared to the industry. FME is cheaper than 86.21% of the companies in the same industry.
  • FME is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.13, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.16
Fwd PE 9.8
FME.DE Price Earnings VS Forward Price EarningsFME.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, FME is valued cheaply inside the industry as 82.76% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, FME is valued a bit cheaper than the industry average as 79.31% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.61
EV/EBITDA 6.01
FME.DE Per share dataFME.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.07%
EPS Next 3Y6.69%

7

5. FME.DE Dividend Analysis

5.1 Amount

  • FME has a Yearly Dividend Yield of 3.74%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 1.93, FME pays a better dividend. On top of this FME pays more dividend than 93.10% of the companies listed in the same industry.
  • FME's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 3.74%

5.2 History

  • The dividend of FME has a limited annual growth rate of 4.43%.
Dividend Growth(5Y)4.43%
Div Incr Years2
Div Non Decr Years3
FME.DE Yearly Dividends per shareFME.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • 43.19% of the earnings are spent on dividend by FME. This is a bit on the high side, but may be sustainable.
  • The dividend of FME is growing, but earnings are growing more, so the dividend growth is sustainable.
DP43.19%
EPS Next 2Y2.07%
EPS Next 3Y6.69%
FME.DE Yearly Income VS Free CF VS DividendFME.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
FME.DE Dividend Payout.FME.DE Dividend Payout, showing the Payout Ratio.FME.DE Dividend Payout.PayoutRetained Earnings

FME.DE Fundamentals: All Metrics, Ratios and Statistics

FRESENIUS MEDICAL CARE AG

FRA:FME (4/7/2026, 3:07:59 PM)

39.3

+0.63 (+1.63%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-24
Earnings (Next)05-05
Inst Owners44.27%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap11.53B
Revenue(TTM)19.63B
Net Income(TTM)978.37M
Analysts65.93
Price Target45.41 (15.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.74%
Yearly Dividend1.48
Dividend Growth(5Y)4.43%
DP43.19%
Div Incr Years2
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.86%
Min EPS beat(2)14.16%
Max EPS beat(2)35.55%
EPS beat(4)4
Avg EPS beat(4)22.94%
Min EPS beat(4)14.16%
Max EPS beat(4)35.55%
EPS beat(8)8
Avg EPS beat(8)21.57%
EPS beat(12)10
Avg EPS beat(12)16.05%
EPS beat(16)12
Avg EPS beat(16)12.94%
Revenue beat(2)1
Avg Revenue beat(2)0.93%
Min Revenue beat(2)-1.71%
Max Revenue beat(2)3.58%
Revenue beat(4)2
Avg Revenue beat(4)0.32%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)3.58%
Revenue beat(8)4
Avg Revenue beat(8)-0.14%
Revenue beat(12)5
Avg Revenue beat(12)-0.25%
Revenue beat(16)7
Avg Revenue beat(16)-0.28%
PT rev (1m)-0.82%
PT rev (3m)-4.61%
EPS NQ rev (1m)15.94%
EPS NQ rev (3m)29.57%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.3%
Revenue NQ rev (1m)-1.21%
Revenue NQ rev (3m)-5.93%
Revenue NY rev (1m)-0.95%
Revenue NY rev (3m)-3.02%
Valuation
Industry RankSector Rank
PE 9.16
Fwd PE 9.8
P/S 0.59
P/FCF 6.61
P/OCF 4.3
P/B 0.87
P/tB N/A
EV/EBITDA 6.01
EPS(TTM)4.29
EY10.92%
EPS(NY)4.01
Fwd EY10.2%
FCF(TTM)5.94
FCFY15.12%
OCF(TTM)9.14
OCFY23.25%
SpS66.89
BVpS45.36
TBVpS-5.17
PEG (NY)N/A
PEG (5Y)N/A
Graham Number66.17
Profitability
Industry RankSector Rank
ROA 3.16%
ROE 7.35%
ROCE 7.13%
ROIC 5.3%
ROICexc 5.78%
ROICexgc 16.63%
OM 9%
PM (TTM) 4.98%
GM 25.62%
FCFM 8.88%
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
ROICexc(3y)4.29%
ROICexc(5y)4.23%
ROICexgc(3y)11.55%
ROICexgc(5y)11.07%
ROCE(3y)5.42%
ROCE(5y)5.44%
ROICexgc growth 3Y23.76%
ROICexgc growth 5Y-0.49%
ROICexc growth 3Y19.48%
ROICexc growth 5Y-3.49%
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
F-Score8
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 6.19
Debt/EBITDA 2.64
Cap/Depr 62.47%
Cap/Sales 4.78%
Interest Coverage 4.9
Cash Conversion 82.09%
Profit Quality 178.22%
Current Ratio 1.26
Quick Ratio 0.92
Altman-Z 1.82
F-Score8
WACC5.01%
ROIC/WACC1.06
Cap/Depr(3y)48.17%
Cap/Depr(5y)48.21%
Cap/Sales(3y)4.06%
Cap/Sales(5y)4.23%
Profit Quality(3y)290.62%
Profit Quality(5y)248.93%
High Growth Momentum
Growth
EPS 1Y (TTM)32%
EPS 3Y11.44%
EPS 5Y-1.51%
EPS Q2Q%58.24%
EPS Next Y-6.53%
EPS Next 2Y2.07%
EPS Next 3Y6.69%
EPS Next 5Y9.03%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-0.29%
Revenue Next Year-0.21%
Revenue Next 2Y1.76%
Revenue Next 3Y2.08%
Revenue Next 5Y3.69%
EBIT growth 1Y39.46%
EBIT growth 3Y11.12%
EBIT growth 5Y-4.66%
EBIT Next Year71.81%
EBIT Next 3Y24.11%
EBIT Next 5Y15.26%
FCF growth 1Y4.8%
FCF growth 3Y7.67%
FCF growth 5Y-11.14%
OCF growth 1Y12.36%
OCF growth 3Y7.35%
OCF growth 5Y-8.73%

FRESENIUS MEDICAL CARE AG / FME.DE Fundamental Analysis FAQ

What is the fundamental rating for FME stock?

ChartMill assigns a fundamental rating of 5 / 10 to FME.DE.


What is the valuation status for FME stock?

ChartMill assigns a valuation rating of 6 / 10 to FRESENIUS MEDICAL CARE AG (FME.DE). This can be considered as Fairly Valued.


How profitable is FRESENIUS MEDICAL CARE AG (FME.DE) stock?

FRESENIUS MEDICAL CARE AG (FME.DE) has a profitability rating of 5 / 10.


Can you provide the financial health for FME stock?

The financial health rating of FRESENIUS MEDICAL CARE AG (FME.DE) is 5 / 10.


How sustainable is the dividend of FRESENIUS MEDICAL CARE AG (FME.DE) stock?

The dividend rating of FRESENIUS MEDICAL CARE AG (FME.DE) is 7 / 10 and the dividend payout ratio is 43.19%.